Posted on Leave a comment

Abdominal Aortic Aneurysm Market to Witness Growth by 2032, Estimates DelveInsight | Endologix LLC, Cardinal Health, Cook Medical, W. L. Gore & Associates Inc., Medtronic, MicroPort Scientific Corp

Abdominal Aortic Aneurysm Market (New York, USA) DelveInsight’s “Abdominal Aortic Aneurysm Market Insights, Epidemiology, and Market Forecast-2032” report delivers an in-depth understanding of Abdominal Aortic Aneurysm, historical and forecasted epidemiology as well as the Abdominal Aortic Aneurysm market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan. The Abdominal […]

Posted on Leave a comment

Adeno-Associated Virus Vector-Based Gene Therapies market is expected to witness growth by 2032, estimates DelveInsight | Biomarin Pharmaceutical, Roche (Spark Therapeutics), Sangamo, Pfizer and other

Adeno-Associated Virus Vector-Based Gene Therapies market DelveInsight estimates that the Adeno-Associated Virus Vector-Based Gene Therapy Market, is anticipated to pick up momentum as companies across the globe are thoroughly working toward the development of new AAV-gene therapies to treat a spectrum of diseases. Leading companies such as Biomarin Pharmaceutical, Roche (Spark Therapeutics), Sangamo, Pfizer, others […]

Posted on Leave a comment

Acid Sphingomyelinase Deficiency (ASMD) Market to Witness Growth by 2032, Estimates DelveInsight | Orphazyme A/S, Okklo Life Sciences, Merck, Genzyme Corporation, La Jolla Pharmaceutical Company

Acid Sphingomyelinase Deficiency (ASMD) Market (New York, USA) DelveInsight’s “Acid Sphingomyelinase Deficiency (ASMD) Market Insights, Epidemiology, and Market Forecast-2032” report delivers an in-depth understanding of Acid Sphingomyelinase Deficiency (ASMD), historical and forecasted epidemiology as well as the Acid Sphingomyelinase Deficiency (ASMD) market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), […]

Posted on Leave a comment

Reactive Arthritis Market to Accelerate Substantially During the Forecast Period (2022-2032) – DelveInsight | Key Companies – AbbVie, Amgen, Bayer, Bristol-Myers Squibb, Geri-Care Pharma

DelveInsight Business Research DelveInsight’s “Reactive Arthritis Market Insights, Epidemiology, and Market Forecast 2032” report delivers an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the Reactive Arthritis market size, share, and trends in the seven major markets (7MM) (i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom) […]

Posted on Leave a comment

Genomics Market worth $83.1 billion | Recent Developments and Trends to 2027

Genomics Market in terms of revenue was estimated to be worth $46.2 billion in 2023 and is poised to reach $83.1 billion by 2028, growing at a CAGR of 12.4% from 2023 to 2028 according to a new report by MarketsandMarkets™ The genomics industry is expected to experience a major boom in the near future. […]

Posted on Leave a comment

Cerebral Amyloid Angiopathy Pipeline Analysis (2023 Updates) | In-depth Insights into the Clinical Trials, Emerging Drugs, Latest FDA, EMA, and PMDA Approvals, Competitive Landscape, and Key Companies

Delveinsight Business Research LLP As per DelveInsight’s assessment, globally, about 10+ key pharma and biotech companies are working on 10+ pipeline drugs in the Cerebral Amyloid Angiopathy therapeutics landscape based on different Routes of Administration (ROA), Mechanism of Action (MOA), and molecule types. Several of the therapies are in the advanced stages of clinical development […]

Posted on Leave a comment

Urea Cycle Disorders Market Size & Share, Trends, Epidemiology and Competitive Insights Report 2032 | Companies – Acer Therapeutics, Aeglea BioTherapeutics

DelveInsight’s “Urea Cycle Disorders – Market Insights, Epidemiology, and Market Forecast-2032” report delivers an in-depth understanding of the Urea Cycle Disorders, historical and forecasted epidemiology as well as the Urea Cycle Disorders market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. DelveInsight’s “Urea Cycle Disorders Market Report 2032” […]

Posted on Leave a comment

Clostridium Difficile Infections Pipeline Analysis (2023 Updates)| In-depth Insights into the Clinical Trials, Emerging Drugs, Latest FDA, EMA, and PMDA Approvals, Competitive Landscape, Key Companies

Delveinsight Business Research LLP As per DelveInsight’s assessment, globally, about 25+ key pharma and biotech companies are working on 25+ pipeline drugs in the Clostridium Difficile Infections (Clostridium Difficile Associated Disease) therapeutics landscape based on different Routes of Administration (ROA), Mechanism of Action (MOA), and molecule types. Several of the therapies are in the advanced […]

Posted on Leave a comment

Amyotrophic Lateral Sclerosis Pipeline Assessment (2023 Updates) | In-depth Insights into the Clinical Trials, Emerging Drugs, Latest FDA, EMA, and PMDA Approvals, Competitive Landscape, Key Companies

Delveinsight Business Research LLP As per DelveInsight’s assessment, globally, about 90+ key pharma and biotech companies are working on 100+ pipeline drugs in the Amyotrophic Lateral Sclerosis therapeutics landscape based on different Routes of Administration (ROA), Mechanism of Action (MOA), and molecule types. Several of the therapies are in the advanced stages of clinical development […]

Posted on Leave a comment

Graft Versus Host Disease (GvHD) Market Size and Share, Trends, Epidemiology and Forecast Report 2032 | Companies – Novartis, Incyte Corporation, CSL Behring

Graft Versus Host Disease Market DelveInsight’s ” Graft Versus Host Disease (GvHD) – Market Insights, Epidemiology, and Market Forecast-2032″ report delivers an in-depth understanding of the Graft Versus Host Disease (GvHD), historical and forecasted epidemiology as well as the Graft Versus Host Disease (GvHD) market trends in the United States, EU5 (Germany, Spain, Italy, France, […]